$ 1.8
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies,...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers.
Target Price
The average target price of CGC is 2.3 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
